Loading chat...
WV HB5482
Bill
Status
2/12/2026
Primary Sponsor
Matthew Rohrbach
Click for details
AI Summary
-
Prohibits health insurers and pharmacy benefit managers from refusing to pay participating providers for covered clinician-administered drugs or requiring these medications to be dispensed only by plan-selected pharmacies
-
Protects patients' right to choose their provider or pharmacy for clinician-administered drugs without financial penalties, steering, or additional cost-sharing beyond standard plan amounts
-
Defines clinician-administered drugs as prescription medications that cannot reasonably be self-administered and are typically given by healthcare professionals in clinical settings such as physician offices or infusion centers
-
Allows insurers to offer, but not require, home infusion or external infusion sites, and permits specialty care centers of excellence based on objective quality measures
-
Violations constitute unfair trade practices subject to penalties under West Virginia's Unfair Trade Practices and Consumer Protection Law, and any contract provisions contrary to these rules are void and unenforceable
Legislative Description
Protecting patient access to clinician-administered medications.
Health
Last Action
To House Health and Human Resources
2/12/2026